Profile
Iain W.
Duncan was the founder of Corus Pharma, Inc. founded in 2001, where he held the title of Vice President-Operations from 2001 to 2008.
He was a Principal at PathoGenesis Corp and Lyondell Chemical Co. He was also a Senior Vice President-Operations at Horizon Therapeutics, Inc. from 2009 to 2010.
Mr. Duncan received an undergraduate degree from Trent University.
Former positions of Iain W. Duncan
| Companies | Position | End |
|---|---|---|
Horizon Therapeutics, Inc.
Horizon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops prescription drugs for mild to moderate pain relief | Chief Operating Officer | 2010-04-04 |
Corus Pharma, Inc.
Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat needs in the infectious diseases and respiratory areas | Founder | 2008-12-03 |
Lyondell Chemical Co.
Lyondell Chemical Co. Finance/Rental/LeasingFinance Functions as a financing subsidiary/special purpose entity | Corporate Officer/Principal | - |
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Develops and markets innovative treatments for chronic infectious diseases | Corporate Officer/Principal | - |
Training of Iain W. Duncan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Develops and markets innovative treatments for chronic infectious diseases | Health Technology |
Lyondell Chemical Co.
Lyondell Chemical Co. Finance/Rental/LeasingFinance Functions as a financing subsidiary/special purpose entity | Finance |
Corus Pharma, Inc.
Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat needs in the infectious diseases and respiratory areas | Health Technology |
Trent University
Trent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Horizon Therapeutics, Inc.
Horizon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops prescription drugs for mild to moderate pain relief | Health Technology |
- Stock Market
- Insiders
- Iain W. Duncan
















